Table 2.
Healthcare resource utilization and associated costs during the 12 months prior to index date
| Healthcare resource utilization and associated costs | Values |
|---|---|
| All-cause HCRU, mean (SD) | |
| Number of hospitalizations | 1.6 (3.2) |
| Length of inpatient stay, in days | 15.6 (32.4) |
| Number of emergency room visits | 0.6 (1.3) |
| Number of outpatient visits | 58.6 (28.6) |
| Number of pharmacy fills | 63.8 (32.1) |
| Total all-cause healthcare costs, mean (SD)a | $468,514 ($287,662) |
| MM-related HCRU, mean (SD) | |
| Number of hospitalizations | 1.4 (2.7) |
| Length of hospitalization stay, in days | 15.2 (32.1) |
| Number of emergency room visits | 0.2 (0.4) |
| Number of outpatient visits | 45.9 (26.0) |
| MM-related healthcare costs, mean (SD)a | |
| Inpatient cost | $45,893 ($111,345) |
| Emergency room cost | $262 ($820) |
| Outpatient cost | $54,467 ($67,004) |
| MM drug cost | $289,820 ($198,741) |
| MM drug infusion cost | $11,937 ($12,001) |
| Stem cell transplant cost | $26,162 ($79,558) |
| Other costs | $3,825 ($2,654) |
| Total costs | $432,366 ($258,634) |
Index date was defined as the initiation date of the first subsequent LOT after meeting the eligibility requirements for the study (i.e. had received ≥ 4 prior LOTs, including TCE)
HCRU Healthcare resource utilization, MM multiple myeloma
aAverage cost for all patients in the sample; all patients may not have incurred cost in each category